Henriksen

Henriksen is a retiree from Pāpāmoa, New Zealand, who has been courageously battling breast cancer since her initial diagnosis in 2009. After a period of being cancer-free, she faced a recurrence in 2021, leading to a diagnosis of advanced HER2-low breast cancer. Recently, she has been in the news advocating for the funding of the cancer drug Enhertu, which is currently not funded by New Zealand's Pharmac for her specific cancer type, despite its availability in over 20 other countries. Henriksen emphasizes the need for equitable access to life-extending treatments for all cancer patients.